TIA’s small molecule drug development pathway is supported by industry-standard and cost-effective compound library management and logistics to support high throughput screening. Compound libraries available in assay-ready formats include open access collections (drug libraries, academic library, scaffolds library), closed access collections (proprietary collections) and specialised collections (NatureBank and Australian Lead Identification Consortium).